Measuring matrix metalloproteinase activity in macrophages and polymorphonuclear leukocytes

Current Protocols in Immunology

Volumn , Issue SUPPL.93, 2011, Pages

  Kessenbrock, Kai ^a   Brown, Markus ^a   Werb, Zena ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Inflammation; Macrophage; MMP; Neutrophil

Indexed keywords

GAMMA INTERFERON; GELATINASE A; GELATINASE B; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL ISOLATION; ENZYME ACTIVITY; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ZYMOGRAPHY;

EID: 82355163943     PISSN: 19343671     EISSN: 1934368X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ardi, V.C., Kupriyanova, T.A., Deryugina, E.I., and Quigley, J.P. 2007. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 104:20262-20267.
2. Bar-Or, A., Nuttall, R.K., Duddy, M., Alter, A., Kim, H.J., Ifergan, I., Pennington, C.J., Bourgoin, P., Edwards, D.R., and Yong, V.W. 2003. Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 126:2738-2749.
3. Bergers, G., Brekken, R., McMahon, G., Vu, T.H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., and Hanahan, D. 2000. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2:737-744.
4. Bonfield, T.L., Swaisgood, C.M., Barna, B.P., Farver, C.F., Kavuru, M.S., and Thomassen, M.J. 2006. Elevated gelatinase activity in pulmonary alveolar proteinosis: Role of macrophage-colony stimulating factor. J. Leukoc. Biol. 79:133-139.
5. Busiek,D.F., Baragi,V., Nehring, L.C., Parks,W.C., and Welgus, H.G. 1995. Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J. Immunol. 154:6484-6491.
6. de Visser, K.E., Eichten, A., and Coussens, L.M. 2006. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6:24-37.
7. Fisher, S. andWerb, Z. 1995. The catabolism of extracellular matrix components. In Extracellular Matrix: A Practical Approach (M.A. Haralson and J.R. Hassell, eds.) pp. 261-287. Oxford University Press, Oxford.
8. Gutierrez-Fernandez, A., Inada, M., Balbín, M., Fueyo, A., Pitiot, A.S., Astudillo, A., Hirose, K.,Hirata, M., Shapiro, S.D., Nöel, A.,Werb, Z., Krane, S.M., López-Otín, C., and Puente, X.S. 2007. Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J. 21:2580-2591.
9. Hattori, S., Fujisaki, H., Kiriyama, T., Yokoyama, T., and Irie, S. 2002. Real-time zymography and reverse zymography: A method for detecting activities ofmatrixmetalloproteinases and their inhibitors using FITC-labeled collagen and casein as substrates. Anal. Biochem. 301:27-34.
10. Houghton, A.M., Hartzell, W.O., Robbins, C.S., Gomis-Rüth, F.X., and Shapiro, S.D. 2009. Macrophage elastase kills bacteria within murine macrophages. Nature 460:637-641.
11. Kahnert, A., Seiler, P., Stein, M., Bandermann, S., Hahnke, K., Mollenkopf, H., and Kaufmann, S.H. 2006. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. Eur. J. Immunol. 36:631-647.
12. Kessenbrock, K., Plaks, V., andWerb, Z. 2010. Ratrix metalloproteinases: Regulators of the tumor microenvironment. Cell 141:52-67.
13. Liu, Z., Zhou, X., Shapiro, S.D., Shipley, J.M., Twining, S.S., Diaz, L.A., Senior, R.M., and Werb, Z. 2000. The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 102:647-655.
14. Matias-Roman, S., Gálvez, B.G., Genís, L., Yáñez-Mó, M., de la Rosa, G., Sánchez-Mateos, P., Sánchez-Madrid, F., and Arroyo, A.G. 2005. Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium. Blood 105:3956-3964.
15. Mostafa Mtairag, E., Chollet-Martin, S., Oudghiri, M., Laquay, N., Jacob, M.P., Michel, J.B., and Feldman, L.J. 2001. Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion. Cardiovasc. Res. 49:882-890.
16. Ortega, N., Wang, K., Ferrara, N., Werb, Z., and Vu, T.H. 2010. Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation. Dis. Model Mech. 3:224-235.
17. Parks, W.C., Wilson, C.L., and Lopez-Boado, Y.S. 2004. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4:617-629.
18. Redondo-Munoz, J., Ugarte-Berzal, E., Terol, M.J., Van den Steen, P.E., Hernández del Cerro, M., Roderfeld, M., Roeb, E., Opdenakker, G., García-Marco, J.A., and García-Pardo, A. 2010. Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain. Cancer Cell 17:160-172.
19. Ridnour, L.A., Windhausen, A.N., Isenberg, J.S., Yeung, N., Thomas, D.D., Vitek, M.P., Roberts, D.D., and Wink, D.A. 2007. Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and- independent pathways. Proc. Natl. Acad. Sci. U.S.A. 104:16898-16903.
20. Sternlicht, M.D. and Werb, Z. 2001. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17:463-516.
21. Taylor, P.R., Martinez-Pomares, L., Stacey, M., Lin, H.H., Brown, G.D., and Gordon, S. 2005. Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23:901-944.